Talzenna

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 0069-1501
  • Package NDC 0069-1501-30
  • Application number NDA211651
  • SPL ID 876ff42d-8d2e-4de9-909e-2aaa956b058c
  • SPL set ID f2423edd-6d24-495c-aec1-c2f457f08d9a
  • UNII 02WK9U5NZC
  • RxCUI 2099946
  • RxCUI 2099952
  • RxCUI 2099954
  • RxCUI 2099956
  • RxCUI 2591510
  • RxCUI 2591512
  • RxCUI 2591520
  • RxCUI 2591521
  • RxCUI 2639960
  • RxCUI 2639962
  • RxCUI 2639964
  • RxCUI 2639966

What the source publishes

Labeler
Pfizer Laboratories Div Pfizer Inc
Active ingredients
talazoparib
Form
CAPSULE
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:0069-1501_876ff42d-8d2e-4de9-909e-2aaa956b058c
{
  "name": "Talzenna",
  "splId": "876ff42d-8d2e-4de9-909e-2aaa956b058c",
  "labels": [
    {
      "setId": "f2423edd-6d24-495c-aec1-c2f457f08d9a",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=f2423edd-6d24-495c-aec1-c2f457f08d9a",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=f2423edd-6d24-495c-aec1-c2f457f08d9a"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "Pfizer Laboratories Div Pfizer Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "1 BOTTLE in 1 CARTON (0069-1501-30)  / 30 CAPSULE in 1 BOTTLE",
      "package_ndc": "0069-1501-30",
      "identifierStatus": "well-formed",
      "marketing_end_date": "20270331",
      "marketing_start_date": "20220131"
    }
  ],
  "productId": "0069-1501_876ff42d-8d2e-4de9-909e-2aaa956b058c",
  "useDomain": "unknown",
  "dosageForm": "CAPSULE",
  "productNdc": "0069-1501",
  "deaSchedule": null,
  "genericName": "talazoparib",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": "20270331",
  "activeIngredients": [
    {
      "name": "TALAZOPARIB TOSYLATE",
      "strength": ".5 mg/1"
    }
  ],
  "applicationNumber": "NDA211651",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20220131",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "unii": [
      "02WK9U5NZC"
    ],
    "rxcui": [
      "2099946",
      "2099952",
      "2099954",
      "2099956",
      "2591510",
      "2591512",
      "2591520",
      "2591521",
      "2639960",
      "2639962",
      "2639964",
      "2639966"
    ],
    "spl_set_id": [
      "f2423edd-6d24-495c-aec1-c2f457f08d9a"
    ],
    "manufacturer_name": [
      "Pfizer Laboratories Div Pfizer Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": null
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:0069-1501_876ff42d-8d2e-4de9-909e-2aaa956b058c"